Substance Use Disorder and Ketamine: Addiction Risk and Contraindications

Active substance use disorder (SUD) is a major contraindication to ketamine therapy. While ketamine has potential for addiction treatment in specialized research settings, its use in patients with active substance use or recent recovery is risky and generally contraindicated due to addiction potential, cross-addiction vulnerability, and the complex neurochemistry involved.

Why Ketamine Is Risky in Substance Use Disorder

Addiction Potential

Ketamine itself can be addictive. While less prone to physical dependence than opioids or benzodiazepines, ketamine can create:

• Psychological dependence: Strong desire to repeat the dissociative experience
• Tolerance: Need for increasing doses to achieve the same effect
• Craving and compulsive use: Particularly in vulnerable individuals

In patients with established substance use disorder, the vulnerability to addiction is heightened.

Cross-Addiction Risk

Patients with SUD have dysregulated reward systems and heightened addiction vulnerability. Introducing another psychoactive substance—even for therapeutic purposes—risks:

• Substitution: Transferring addiction from one drug (alcohol, opioids) to another (ketamine)
• Polysubstance use: Using ketamine alongside other drugs
• Relapse triggers: Dissociative experience may resemble or trigger cravings for prior substances of abuse
• Reduced insight and impulse control: SUD affects executive function; using ketamine may worsen decision-making around substance use

Neurotransmitter Disruption

SUD causes profound dysregulation of dopamine, serotonin, and glutamate systems. Ketamine's action on glutamate (NMDA receptor blocking) could:

• Interact unpredictably with recovering dopamine systems
• Worsen craving or withdrawal
• Impair the neuroadaptation necessary for recovery
• Create additional neurochemical chaos

Impaired Judgment and Relapse Risk

Ketamine's dissociative effects impair judgment and self-awareness. In someone with active SUD or early recovery, this could:

• Reduce adherence to sobriety commitments
• Increase risky decision-making (drug use, unsafe behaviors)
• Interfere with 12-step programs or addiction therapy
• Worsen comorbid psychiatric symptoms (depression, anxiety) that fuel relapse

Defining "Active" vs. "Recovered" SUD

Active Substance Use Disorder

• Current use of alcohol, opioids, stimulants, sedatives, or other drugs in a pattern meeting diagnostic criteria
• No abstinence: Use is ongoing
• Contraindication: Absolute. Do not offer ketamine.

Early Recovery (< 6 Months Sobriety)

• Abstinent from primary substance
• Recent sobriety: < 6 months
• High relapse risk: Brain neurochemistry still significantly dysregulated
• Contraindication: Relative. Avoid ketamine unless exceptional circumstances and specialized addiction co-management.

Stable Long-Term Recovery (> 1-2 Years)

• Sustained abstinence: 1-2+ years sober
• Neurochemical recovery: Brain dopamine systems partially restored
• Psychological recovery: Developed coping skills, insight, recovery network
• Potential consideration: Ketamine might be cautiously considered if:
• Serious treatment-resistant depression or PTSD
• Addiction specialist clearance
• Strong recovery network in place
• Intensive monitoring
• Careful informed consent about relapse risk
• Individual assessment of vulnerability

Screening for Substance Use Disorder

If considering ketamine, providers should screen for:

• Personal history: Any prior substance abuse or addiction?
• Current use: Alcohol, cannabis, opioids, stimulants, sedatives, other drugs?
• Frequency and quantity: Daily use? Binge use? Loss of control?
• Negative consequences: Legal, financial, relationship, health problems related to use?
• Family history: Parents, siblings, or relatives with substance abuse?
• Genetic vulnerability: Family history of addiction increases risk
• Mental health history: Depression, anxiety, trauma—these increase relapse risk

Validated Screening Tools:

• AUDIT (Alcohol Use Disorders Identification Test): For alcohol
• DAST-10 (Drug Abuse Screening Test): For drug use
• OARRS (Prescription Opioid Addiction Risk): For opioid vulnerability

Positive screens warrant specialist addiction assessment before considering ketamine.

Safe Alternatives for Depression/Anxiety in SUD

Many effective treatments exist for comorbid depression and SUD that don't carry ketamine's addiction risk:

Medications (Addiction-Safe):

• SSRIs: Sertraline, fluoxetine—safe in SUD; may reduce drinking in alcohol use disorder
• Naltrexone: Opioid antagonist; blocks euphoria from opioids, may reduce cravings
• Acamprosate: Reduces alcohol cravings and withdrawal symptoms
• Buprenorphine: For opioid use disorder; has anti-depressant properties
• Buspirone: For anxiety; low abuse potential

Behavioral Therapies:

• Cognitive-Behavioral Therapy (CBT): Highly effective for co-occurring depression and SUD
• Contingency Management: Rewards abstinence; powerful for motivation
• 12-Step Programs: AA, NA, SMART Recovery—community support and structure
• Motivational Interviewing: Enhances intrinsic motivation for change
• Family Therapy: Addresses family dynamics fueling substance use

Lifestyle & Social:

• Exercise: Robust evidence for mood improvement in SUD
• Sleep optimization: Addresses withdrawal-related insomnia
• Social connection: Sober friends, recovery community
• Occupational engagement: Work, school, hobbies—structure reduces relapse

Specialized Programs:

• Inpatient/residential treatment: For severe SUD
• Intensive outpatient programs (IOP): Structured day treatment
• Medication-assisted treatment (MAT): Buprenorphine or methadone for opioid SUD
• EMDR or trauma therapy: For trauma-related substance use

Ketamine in Specialized Addiction Research

Notably, ketamine is being studied for specific addiction applications:

• Alcohol use disorder: Some research suggests ketamine + psychotherapy may enhance extinction of alcohol-related memories
• Opioid use disorder: Emerging research in patients on medication-assisted treatment
• PTSD + SUD: Ketamine for co-occurring PTSD and addiction

However, these are specialized research settings with close monitoring, not standard clinical practice. If considering participation in a research study, discuss risks thoroughly with the research team and your addiction specialist.

If You're in Recovery and Interested in Ketamine

1. Discuss with your addiction specialist first: Essential input from someone who knows your recovery vulnerabilities
2. Assess your recovery stability: How long sober? How strong is your recovery network?
3. Evaluate alternatives: Are there safer treatments?
4. Set clear boundaries: If proceeding, establish relapse prevention strategies
5. Intensive monitoring: Close contact with both addiction and ketamine providers
6. Accountability: Family member or sponsor who monitors closely
7. Crisis plan: Clear steps if relapse or addiction urges emerge

Frequently Asked Questions

Can I get ketamine if I'm in a 12-step program?

Discuss with your sponsor and addiction counselor. Being actively engaged in recovery is a positive sign, but the addiction risk of ketamine itself remains.

What if I've been sober for 5 years?

Long-term sobriety is excellent and significantly reduces addiction risk. However, individual vulnerability assessment is still needed. Discuss with your addiction specialist about your specific relapse risk factors.

Is there a "safe" dose of ketamine for people with SUD?

There's no dose that eliminates addiction risk in vulnerable individuals. The risk is fundamentally about the drug's effects on the recovering brain—not just about dose.

What if I was addicted to a different substance (alcohol, not opioids)?

Addiction to any substance reflects dysregulated reward systems and decision-making. Vulnerability to other addictive substances remains elevated—including ketamine.

Can I use ketamine once I'm off all substances?

That depends on individual factors: time sober, strength of recovery, comorbid psychiatric conditions, support systems. Addiction specialist assessment is essential.

The Bottom Line

Active substance use disorder is a major contraindication to ketamine. Early recovery (< 6-12 months sobriety) also warrants caution. If you have SUD or are in recovery and are interested in ketamine, start by consulting your addiction specialist to assess your individual vulnerability, then collaborate with your mental health team on safer alternatives. Many evidence-based treatments exist for depression and anxiety in SUD that don't carry ketamine's addiction risk.

For residents of Florida and New Jersey interested in evidence-based addiction treatment alongside mental health care, consult with our team about safe, integrated approaches to your recovery.